Nrf2调控小鼠CD4+ T细胞诱导的急性移植物抗宿主病
该研究在小鼠同种异体造血细胞移植模型中,发现Nrf2在T细胞活化后表达及核转位增加,尤其见于移植后的供者CD4+ T细胞;接受Nrf2-/-供者T细胞的小鼠急性GVHD死亡率、发病率及病理显著降低,且移植物抗肿瘤活性保留,提示Nrf2是T细胞功能的新调控因子及改善allo-HCT结局的潜在治疗靶点。
要点
- Nrf2在T细胞活化后表达及核转位增加,尤其见于allo-HCT后的供者CD4+ T细胞。
- 接受Nrf2-/-供者T细胞的小鼠急性GVHD死亡率、发病率及病理显著降低。
- Nrf2-/-供者CD8+ T细胞对同种异体靶细胞的细胞毒性完整,抗肿瘤活性保留。
核心结论
- 研究表征了Nrf2在T细胞功能中此前未被认识的作用,并揭示了改善allo-HCT结局的新治疗靶点。
研究设计与样本
- 研究为小鼠同种异体造血细胞移植(allo-HCT)模型研究,涉及体外T细胞活化及供者T细胞过继转移。
主要发现
- 体外T细胞活化后Nrf2表达及核转位增加,尤其见于allo-HCT后的供者CD4+ T细胞。
- 接受Nrf2-/-供者T细胞的小鼠急性GVHD诱导的死亡率、发病率及病理显著降低。
- GVHD降低与移植物中Helios+供者调节性T细胞持续存在及同种反应性CD8+ T细胞上肠道归巢受体LPAM-1上调缺陷相关。
- Nrf2-/-供者CD8+ T细胞对同种异体靶细胞表现出完整的细胞毒性。
- 荷瘤allo-HCT受者接受Nrf2-/-供者T细胞后,因移植物抗肿瘤活性保留且GVHD活性降低,总生存改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nuclear factor erythroid-derived 2-like 2 (Nrf2) is a ubiquitously expressed transcription factor that is well known for its role in regulating the cellular redox pathway. Although there is mounting evidence suggesting a critical role for Nrf2 in hematopoietic stem cells and innate leukocytes, little is known about its involvement in T-cell biology. In this study, we identified a novel role for Nrf2 in regulating alloreactive T-cell function during allogeneic hematopoietic cell transplantation (allo-HCT). We observed increased expression and nuclear translocation of Nrf2 upon T-cell activation in vitro, especially in CD4+ donor T cells after allo-HCT. Allo-HCT recipients of Nrf2 -/- donor T cells had significantly less acute graft-versus-host disease (GVHD)-induced mortality, morbidity, and pathology. This reduction in GVHD was associated with the persistence of Helios+ donor regulatory T cells in the allograft, as well as defective upregulation of the gut-homing receptor LPAM-1 on alloreactive CD8+ T cells. Additionally, Nrf2 -/- donor CD8+ T cells demonstrated intact cytotoxicity against allogeneic target cells. Tumor-bearing allo-HCT recipients of Nrf2 -/- donor T cells had overall improved survival as a result of preserved graft-versus-tumor activity and reduced GVHD activity. Our findings characterized a previously unrecognized role for Nrf2 in T-cell function, as well as revealed a novel therapeutic target to improve the outcomes of allo-HCT.
引用
- Tsai JJ, Velardi E, Shono Y, et al. Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice. Blood. 2018. PMID: 30381375. doi:10.1182/blood-2017-10-812941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。